CNS Pharmaceuticals
CNSP • NASDAQ
CNS Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Rami Levin, with a market cap of $2.8M.
CEORami Levin
Market Cap$2.8M
Biotechnology
Healthcare
Employees3.0
Websitecnspharma.com
Country
United States of America
Next Earnings
No upcoming earnings scheduled for CNS Pharmaceuticals
No earnings announcement scheduled
Earnings History
Past 12 earnings reports for CNS Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 17, 2025 | Q3 2025 | -$5.76Est: -$6.63 | +13.1% | - | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$6.42 | — | - | — | 10-Q |
| May 16, 2025 | Q4 2024 | -$1.58Est: -$6.00 | +73.7% | - | — | — |
| Nov 15, 2024 | Q3 2024 | -$12.50Est: -$5.00 | -150.0% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$336.00 | — | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$1,025.00 | — | - | — | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$2,375.00 | — | - | — | — |
| Nov 14, 2023 | Q3 2023 | -$2,700.00 | — | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$2,600.00 | — | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$6,475.00 | — | - | — | 10-Q |
| Apr 3, 2023 | Q4 2022 | -$9,550.00 | — | - | — | — |
| Nov 10, 2022 | Q3 2022 | -$6,750.00Est: -$6,000.00 | -12.5% | - | — | — |